Share
Tweet
close
I Wish I Knew What I Know Now: Conversations with AGG on FDA Issues - Key Due Diligence Issues to Consider When Acquiring or Investing in Life Sciences Companies or Products
by
Alan Minsk
,
Brian Teras
|
Arnall Golden Gregory LLP
×